Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 450 of 715 entries
View as:

Safety and Efficacy of Pimecrolimus Ophthalmic Suspension in Patients With Moderate to Severe Keratoconjunctivitis Sicca

Phase: N/A Priority: Normal
NCT ID: NCT00128245 Org: User:
Start: 09/30/04 End: 12/31/06 Due: 12/31/07

A Study of Efficacy of New Doses of Xolair to Protect From Allergen Challenge in Groups of Asthma Patients Defined by IgE Levels

Phase: N/A Priority: Normal
NCT ID: NCT00624832 Org: User:
Start: 02/29/08 End: 01/31/09 Due: 01/31/10

A Clinical Study to Evaluate the Long-term Safety (12 Months) of the Combination of Aliskiren 300 mg and Hydrochlorothiazide 25 mg

Phase: N/A Priority: Normal
NCT ID: NCT00171405 Org: User:
Start: 06/30/05 End: 02/28/06 Due: 02/28/07

Extension Study of Pimecrolimus Cream in Pediatric Patients With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT00231998 Org: User:
Start: 05/31/04 End: 06/30/05 Due: 06/30/06

Efficacy and Safety of Diclofenac Sodium (0.1%) Gel in Patients With UV Induced Painful Sunburn

Phase: N/A Priority: Normal
NCT ID: NCT00441051 Org: User:
Start: 11/30/06 End: 12/31/06 Due: 12/31/07

A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00170937 Org: User:
Start: 11/30/04 End: - Due: -

Assessment of Pain and Quality of Life in Breast and Prostate Cancer Patients With Bone Metastases

Phase: N/A Priority: Normal
NCT ID: NCT00434317 Org: User:
Start: 08/31/05 End: - Due: -

A Real-world Study to Assess the Use of Siponimod in Spain to Treat Patients With Secondary Progressive Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT06588387 Org: User:
Start: 11/03/22 End: 09/08/23 Due: 09/08/24

A Real-world Study of Effectiveness and Safety in HR+/HER2- Breast Cancer Patients Treated With Ribociclib or Alpelisib

Phase: N/A Priority: Normal
NCT ID: NCT06705504 Org: User:
Start: 06/11/21 End: 11/30/23 Due: 11/30/24

Switching to Iloperidone From Other Antipsychotics in Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01207414 Org: User:
Start: 08/31/10 End: 01/31/12 Due: 01/31/13

Safety and Efficacy of Aliskiren + Hydrochlorothiazide (± Amlodipine 5 mg) in Patients With Moderate Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00867490 Org: User:
Start: 03/31/09 End: 08/31/09 Due: 08/31/10

Safety and Efficacy of Basiliximab in Calcineurin Inhibitor Intolerant Long-term Kidney Transplant Recipients Treated With Mycophenolic Acid and Steroids

Phase: N/A Priority: Normal
NCT ID: NCT00284947 Org: User:
Start: 01/31/06 End: 12/31/08 Due: 12/31/09

Safety and Efficacy of Converting Maintenance Kidney and Liver Transplant Recipients With Abnormal Glucose Metabolism From Tacrolimus to Cyclosporine Micro-emulsion

Phase: N/A Priority: Normal
NCT ID: NCT00150085 Org: User:
Start: 02/29/04 End: 10/31/05 Due: 10/31/06

Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT00333138 Org: User:
Start: 05/31/03 End: 04/30/11 Due: 04/30/12

Efficacy, Safety, and Tolerability of Oxcarbazepine Monotherapy in Children With Partial Seizures

Phase: N/A Priority: Normal
NCT ID: NCT00275912 Org: User:
Start: 09/11/06 End: 09/28/07 Due: 09/28/08

Treatment Persistence of Biologics in Patients with PsA in Japan; Retrospective Cohort Study Using a Claims Database

Phase: N/A Priority: Normal
NCT ID: NCT06600009 Org: User:
Start: 10/17/22 End: 09/15/23 Due: 09/15/24

Safety and Immunogenicity of Two Intradermal Rabies Vaccine Regimens Administered With and Without Human Rabies Immunoglobulin in Subjects ≥ 1 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT02177032 Org: User:
Start: 06/30/14 End: 08/31/15 Due: 08/31/16

Reconstitution With Pimecrolimus Cream 1% of Steroid-damaged Skin in Adults With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT00367393 Org: User:
Start: 03/31/06 End: 12/31/07 Due: 12/31/08

Safety and Immunogenicity of Three Commercially Available Influenza Vaccines in Children Aged 6 to <36 Months

Phase: N/A Priority: Normal
NCT ID: NCT00311428 Org: User:
Start: 10/31/05 End: - Due: -

A Real-world Study to Assess the Characteristics and Long-term Effectiveness of Inclisiran in Chinese Adult Patients

Phase: N/A Priority: Normal
NCT ID: NCT06595069 Org: User:
Start: 04/30/24 End: 07/10/24 Due: 07/10/25

Local Tolerability and Safety of Povidone K25 Eye Drops (Artificial Tears Containing Povidone) Versus Placebo in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00135824 Org: User:
Start: 03/31/04 End: 05/31/04 Due: 05/31/05

Safety and Tolerability of Repeated Subcutaneous Injections of CAD 106 in Mild Alzheimer's Patients

Phase: N/A Priority: Normal
NCT ID: NCT00795418 Org: User:
Start: 10/31/08 End: - Due: -

26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT00463567 Org: User:
Start: 04/30/07 End: 08/31/08 Due: 08/31/09

Safety and Tolerability of Omalizumab in Adults and Adolescents With Severe Allergic Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00482248 Org: User:
Start: 06/30/03 End: 06/30/06 Due: 06/30/07

Trial to Evaluate the Efficacy of Fluvastatin on Certain Markers

Phase: N/A Priority: Normal
NCT ID: NCT00171262 Org: User:
Start: 08/31/04 End: 06/30/07 Due: 06/30/08